Ophthalmology · Dover, DE
NPI
1700017902
Since 2009
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
833 S Governors Ave
Dover, DE, 19904
Phone (302) 674-1121
Groups this clinician bills Medicare through
Medicare paid, 2024
$975K
11,750 services
Medicare patients, 2024
2,705
Average age 76
Drug cost, 2024
$438K
3,483 prescriptions
Company payments, 2025
$422
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy F Doyle was code 99213 (office e&m - established), 2,329 times for 1,464 patients. In total Timothy F Doyle billed 11,750 services in 35 codes, and Medicare paid $975K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,329 | 1,464 | $57.86 | $135K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,828 | 1,255 | $27.81 | $51K |
| 99214 Office E&M - Established | Office | 1,617 | 1,446 | $84.17 | $136K |
| 92083 Vision, Hearing, and Speech Services | Office | 822 | 802 | $42.37 | $35K |
| 92250 Angiography | Office | 784 | 768 | $23.94 | $19K |
| 92136 Ultrasound - Nonspecific | Office | 623 | 348 | $27.76 | $17K |
| 92020 Ophthalmological E&M | Office | 514 | 510 | $18.25 | $9,379 |
| 66984 Cataract Surgery | Facility | 499 | 287 | $415.96 | $208K |
| 68841 Eye | Facility | 397 | 223 | $12.55 | $4,982 |
| 92133 Computerized Ophthalmic Imaging | Office | 340 | 336 | $23.72 | $8,066 |
| J0178 Injection, aflibercept, 1 mg | Office | 216 | 53 | $661.19 | $143K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 168 | 14 | $263.27 | $44K |
| 66821 Cataract Surgery | Office | 158 | 116 | $251.55 | $40K |
| 67028 Intravitreal Injection | Office | 147 | 65 | $83.09 | $12K |
| 99204 Office E&M - New | Office | 120 | 120 | $101.91 | $12K |
By year: 2022 $1.2M for 13,188 services; 2023 $1.0M for 12,452 services; 2024 $975K for 11,750 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy F Doyle prescribed most often to Medicare patients was Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat), with 657 prescriptions and refills. In total Timothy F Doyle wrote 3,483 Medicare prescriptions that cost $438K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 657 | 1,307 | 174 | $10K |
| Latanoprost Generic | 579 | 1,377 | 173 | $12K |
| Prednisolone Acetate Generic | 328 | 464 | 256 | $9,893 |
| Brimonidine Tartrate Generic | 293 | 629 | 85 | $41K |
| Moxifloxacin Moxifloxacin Hcl | 229 | 230 | 134 | $5,199 |
| Timolol Maleate Generic | 190 | 482 | 56 | $5,921 |
| Dorzolamide Hcl Generic | 163 | 359 | 52 | $3,112 |
| Ketorolac Tromethamine Generic | 160 | 191 | 72 | $3,077 |
| Lumigan Bimatoprost | 98 | 243 | 31 | $61K |
| Travoprost Generic | 71 | 151 | 18 | $14K |
| Atropine Sulfate Generic | 67 | 76 | 62 | $1,965 |
| Lotemax Sm Loteprednol Etabonate | 59 | 61 | 35 | $13K |
| Erythromycin Erythromycin Base | 56 | 61 | 39 | $608 |
| Combigan Brimonidine Tartrate/Timolol | 52 | 94 | 12 | $24K |
| Ilevro Nepafenac | 44 | 64 | 25 | $16K |
Brand drugs: 1,160 claims; generic drugs: 2,323 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy F Doyle $422 ($422 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $81.82.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $81.82 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $76.92 |
| Alcon Vision LLC ALC | 2 | $56.15 |
| Genentech USA, Inc. ROG.SW | 2 | $36.89 |
| Astellas Pharma US Inc 4503.T | 1 | $33.99 |
| Dompe US, Inc. | 1 | $31.77 |
| Abbvie Inc. ABBV | 1 | $24.63 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $22.72 |
| RxSight Inc RXST | 1 | $22.62 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $19.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.